To better understand the biology of cells and their dynamic metabolic response to therapeutic compounds, advanced methodologies are required. Results from two technologies that measure metabolic pathway utilization at two scales, cellular and molecular, can be combined. The Seahorse XF analyzer provides measurements at a cellular resolution, whereas omics and qualitative flux analyses using Revident LC/Q-TOF give measurements at the molecular resolution.